Printer Friendly

Printed from http://www.researchandmarkets.com/reports/364799

U.S. Growth Factors Markets

Description:


Medicinal Possibilities Hold Promise of Prosperous Market

Growth factor proteins are found naturally within the body and are essential
to the growth and repair of human tissue. Recent advances in genomic

technology have enabled scientists to identify the specific genes responsible
for their creation. This has allowed for the large-scale production of growth
factors, creating a market that holds tremendous promise.

This Frost & Sullivan analysis provides a comprehensive examination of the
U.S. growth factors markets. By identifying industry drivers and evaluating
emerging challenges, this study supplies your company with a resourceful
guide to market success.

Aging Population Fuels Need for More Effective, Less Invasive Therapies

One of the greatest challenges facing the healthcare providers who treat
America’s aging population is providing access to effective therapeutics that
stimulate repair in tissues and organ systems damaged by age and disease.
Currently, there are insufficient therapies that address the underlying loss of
tissue function inherent in degenerative disorders.

Alzheimer’s disease, malignancies, trauma, autoimmune disorders, and other

similar conditions create the need for more efficient and less invasive
therapies,” says the author. “It is expected that the increase in age-related

diseases will be the most crucial driver for the growth factors industry over
the next decade.

Development of New Delivery Methods Drive Industry Evolution

Growth factors resulted from the advent of human recombinant
technologies, where biotechnology successfully mimicked the necessary
regulatory proteins for the treatment of certain ailments. Thus, new
systems are also being developed for better delivery of growth factors.
As drug discovery continues to evolve, the number of proteins that will be
discovered, sequenced, and applied to treat human diseases will increase
exponentially,” states the analyst. “Innovative delivery systems will heighten

acceptance for the use of growth factors as viable and effective therapies well
into the future.”

This Frost & Sullivan study provides an in-depth analysis of the marketplace,

offering your company the inside information necessary to take advantage of
lucrative opportunities.

Additional Information

Market Participants
Amgen, Inc.
Aurogen, Inc.
Berlex Laboratories, Inc.
Biogen, Inc.
Biomira, Inc.
Boston Life Sciences, Inc.

CelMed
Chiron Corp.
Corvas International, Inc.
CuraGen Corp.
Curis, Inc.
Cytokine PharmaSciences, Inc.
Demegen, Inc.
Genentech, Inc.
Howmedica/Stryker Corp.
Human Genome Sciences, Inc.
Immunex Corp.
Interferon Sciences, Inc.
Johnson & Johnson/Ortho-McNeil
Ligand Pharmaceuticals, Inc.
Medtronic, Inc.
NeoTherapeutics, Inc.
Nobex Corp.
Receptron, Inc.
Regeneron Pharmaceuticals, Inc.

Regenesis
Roche Diagnostics Corp.
Schering-Plough Corp.
Scios, Inc.
Sigma-Aldrich Co.
Stryker Corp.
Sulzer Biologic, Inc.
SuperGen, Inc.

Theratechnologies

Wyeth Ayerst
ZymoGenetics, Inc.

Aerospace

Auto ID

Biotech

Chemicals

Conferencing

Consumer

e-Business

Environment

Food

Healthcare

Internet Security

IT

Latin America

Medical Devices

Motors

Pharmaceuticals

Power

Sensors

Smart Cards

Technical Insights

Telecom Services

Transportation

Water

Wireless

 
Contents:
1. Executive Summary
A. Executive Summary

1. Executive Summary

2. Total Market
A. Overview

1. Introduction

2. Challenges

3. Market Drivers

4. Market Restraints

5. Market Engineering Analysis
B. Forecasts and Trends

1. Revenue Forecasts

2. Demand Analysis

3. Pricing Trends
C. Frost & Sullivan Market Engineering Awards

1. Entrepreneurial Company Award

2. Market Penetration Award

3. Product Differentiation Innovation Award

4. Strategic Alliance Innovation Award

5. Technology Innovation Award

3. Blood Growth Factors Market
A. Blood Growth Factors - Overview

1. Introduction

2. Challenges

3. Market Drivers

4. Market Restraints

5. Market Engineering Analysis
B. Erythropoietins

1. Overview

2. Demand Analysis

3. Product Analysis
C. Colony Stimulating Growth Factors

1. Overview

2. Demand Analysis

3. Product Analysis
D. Interleukins (Cytokines)

1. Overview

2. Demand Analysis

3. Product Analysis
E. Interferons

1. Overview

2. Demand Analysis

3. Product Analysis
F. Blood Growth Factors - Forecasts and Trends

1. Revenue Forecasts

2. Revenue Forecast Assumptions

3. Market and Technology Trends

4. Pricing Trends
G. Blood Growth Factors - Competitive Analysis

1. Competitive Structure

2. Market Share Analysis
H. Blood Growth Factors - Strategic Recommendations

1. Strategic Recommendations for Market Challenge 1

2. Strategic Recommendations for Market Challenge 2

4. Tissue Growth Factors Market
A. Tissue Growth Factors - Overview

1. Introduction

2. Challenges

3. Market Drivers

4. Market Restraints

5. Market Engineering Analysis
B. Wound Healing Growth Factors

1. Overview

2. Demand Analysis

3. Product Analysis
C. Neurotrophic Growth Factors

1. Overview

2. Demand Analysis

3. Product Analysis
D. Musculoskeletal Tissue Growth Factors

1. Overview

2. Demand Analysis

3. Product Analysis
E. Tissue Growth Factors - Forecasts and Trends

1. Revenue Forecasts

2. Revenue Forecast Assumptions

3. Market and Technology Trends

4. Pricing Trends
F. Tissue Growth Factors - Competitive Analysis

1. Competitive Structure

2. Market Share Analysis
G. Tissue Growth Factors - Strategic Recommendations

1. Strategic Recommendations for Market Challenge 1

2. Strategic Recommendations for Market Challenge 2

3. Strategic Recommendations for Market Challenge 4

List Of Figures

Chapter 2

Growth Factors Market: Market Challenges Ranked in Order of Impact (U.S.), 2001-2008
Growth Factors Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Growth Factors Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Growth Factors Market: Total Revenue Forecasts (U.S.), 1998-2008
Growth Factors Market: Revenue Forecasts by Product Type (U.S.), 1998-2008
Growth Factors Market: Demand Analysis by Condition (U.S.), 1998-2008
Growth Factors Market: Pricing (U.S.), 2001

Chapter 3

Blood Growth Factors Market: Market Challenges Ranked in Order of Impact (U.S.), 2001-2008
Blood Growth Factors Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Blood Growth Factors Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Blood Growth Factors Market: Erythropoietin Demand Analysis (U.S.), 1998-2008
Blood Growth Factors Market: Colony Stimulating Growth Factors and Their Primary Functions (U.S.), 2001
Blood Growth Factors Market: Colony Stimulating Factors Demand Analysis (U.S.), 1998-2008
Blood Growth Factors Market: Interleukins and Their Primary Functions (U.S.), 2001
Blood Growth Factors Market: Interleukin Demand Analysis (U.S.), 1998-2008
Blood Growth Factors Market: Interferon Demand Analysis (U.S.), 1998-2008
Blood Growth Factors Market: Interferon Product Analysis (U.S.), 2001
Blood Growth Factors Market: Total Revenue Forecasts (U.S.), 1998-2008
Blood Growth Factors Market: Total Revenue Forecasts by Product Type (U.S.), 1998-2008
Blood Growth Factors Market: Pricing (U.S.), 2001
Blood Growth Factors Market: Competitive Structure (U.S.), 2001
Blood Growth Factors Market: Market Share Trends of Major Market Participants— Erythropoietins (U.S.), 2001-2002
Blood Growth Factors Market: Market Share Trends of Major Market Participants—Colony Stimulating Growth Factors (U.S.), 2001-2002
Blood Growth Factors Market: Market Share Trends of Major Market Participants— Interleukins (U.S.), 2001-2002
Blood Growth Factors Market: Market Share Trends of Major Market Participants— Interferons (U.S.), 2001-2002

Chapter 4

Tissue Growth Factors Market: Market Challenges Ranked in Order of Impact (U.S.), 2001-2008
Tissue Growth Factors Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Tissue Growth Factors Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Tissue Growth Factors Market: Demand Analysis by Condition (U.S.), 1998-2008
Tissue Growth Factors Market: Wound Growth Factors—Product Analysis (U.S.), 2001
Tissue Growth Factors Market: Neurotrophic Growth Factors—Demand Analysis by Condition (U.S.), 1998-2008
Tissue Growth Factors Market: Neurotrophic Growth Factors—Product Analysis (U.S.), 2001
Tissue Growth Factors Market: Musculoskeletal Growth Factors—Demand Analysis by Condition and by Procedure (U.S.), 1998-2008
Tissue Growth Factors Market: Musculoskeletal Growth Factors—Product Analysis (U.S.), 2001
Tissue Growth Factors Market: Total Revenue Forecasts (U.S.), 1998-2008
Tissue Growth Factors Market: Revenue Forecasts by Type of Growth Factor (U.S.), 1998-2008
Tissue Growth Factors Market: Pricing (U.S.), 2001
Tissue Growth Factors Market: Competitive Structure (U.S.), 2001
Tissue Growth Factors Market: Market Share Trends of Major Market Participants—Wound Growth Factors (U.S.), 2005-2006
Tissue Growth Factors Market: Market Share Trends of Major Market Participants—Neurotrophic Growth Factors (U.S.), 2005-2006
Tissue Growth Factors Market: Market Share Trends of Major Market Participants—Musculoskeletal Growth Factors (U.S.), 2001-2002


 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/364799

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Nov 23, 2014
1:22:01 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

U.S. Growth Factors Markets

Web Address

http://www.researchandmarkets.com/reports/364799

Office Code

SCOI7T

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Site License USD 3,950
Electronic (PDF) - Enterprisewide USD 5,450
Electronic and Hard Copy (PDF) - Enterprisewide USD 5,950 + USD 64 Shipping/Handling *
Electronic and Hard Copy (PDF) - Site License USD 4,450 + USD 64 Shipping/Handling *

* Shipping/Handling is only charged once per order.

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Nov 23, 2014
1:22:01 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)